Swapnil Jatinbhai Shah
Patrimonio netto: 80 M $ in data 31/07/2026
Patrimonio netto: 80 M $ in data 31/07/2026
Swapnil Jatinbhai Shah is Non-Executive Chairman at Remus Pharmaceuticals Ltd. since 2015.
Holds the position of Managing Director & Executive Director at Senores Pharmaceuticals Ltd. since 2021.
Serves as Director at Ratnagene Lifescience Pvt Ltd., Relius Lifesciences Pvt Ltd., Ratnatris Pharmaceuticals Pvt Ltd., Calypso Hospitality LLP, Sumer Enterprises LLP, Renosen Pharmaceuticals Pvt Ltd., Espee Therapeutics LLP, Aelius Projects LLP, Havix Group, Inc., and Senores Pharmaceuticals, Inc. Education includes an MBA from Hofstra University and undergraduate degrees from Gujarat University and Nirma University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/03/2026 | 5.848.031 ( 12,7% ) | 80 M $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| REMUS PHARMACEUTICALS LIMITED | Presidente | 21/09/2015 |
| SENORES PHARMACEUTICALS LIMITED | Amministratore Delegato | 15/10/2021 |
Relius Lifesciences Pvt Ltd. | Direttore/Membro del Consiglio | - |
Renosen Pharmaceuticals Pvt Ltd. | Direttore/Membro del Consiglio | - |
Ratnatris Pharmaceuticals Pvt Ltd.
Ratnatris Pharmaceuticals Pvt Ltd. Ratnatris Pharmaceuticals Pvt Ltd. is a pharmaceutical company specializing in the development, manufacturing, and supply of affordable, high-quality generic medicines and innovative formulations. Ratnatris operates seven advanced manufacturing facilities, including a US FDA-approved plant in the USA, and produces oral solids, parenterals, beta lactams, and cephalosporins. The company is based in Ahmedabad, India. The Indian company offers a broad portfolio of over 500 commercial products across multiple therapeutic categories, including anaesthetics, anti-infectives, cardiovascular, central nervous system, and nutritional supplements. The company focuses on continuous innovation, developing complex generics supported by robust R&D, clinical trials, regulatory compliance, and intellectual property expertise. Ratnatris maintains stringent quality standards aligned with WHO cGMP and ISO 9001:2008, and holds certifications from various national health authorities. | Direttore/Membro del Consiglio | - |
Ratnagene Lifescience Pvt Ltd. | Direttore/Membro del Consiglio | - |
Espee Therapeutics LLP | Direttore/Membro del Consiglio | - |
Aelius Projects LLP | Direttore/Membro del Consiglio | - |
Calypso Hospitality LLP | Direttore/Membro del Consiglio | - |
| ░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 15 |
|---|---|
Hofstra University
Hofstra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gujarat University
Gujarat University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nirma University
Nirma University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Havix Group, Inc.
Havix Group, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Senores Pharmaceuticals Pvt Ltd.
Senores Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical and generic medicines | Health Technology |
Remus Pharmaceuticals Ltd.
Remus Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products with expertise in neurology, cardiology & gastroenterology | Health Technology |
Senores Pharmaceuticals, Inc.
Senores Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceuticals | Health Technology |
Ratnagene Lifescience Pvt Ltd. | |
Relius Lifesciences Pvt Ltd. | |
Ratnatris Pharmaceuticals Pvt Ltd.
Ratnatris Pharmaceuticals Pvt Ltd. Ratnatris Pharmaceuticals Pvt Ltd. is a pharmaceutical company specializing in the development, manufacturing, and supply of affordable, high-quality generic medicines and innovative formulations. Ratnatris operates seven advanced manufacturing facilities, including a US FDA-approved plant in the USA, and produces oral solids, parenterals, beta lactams, and cephalosporins. The company is based in Ahmedabad, India. The Indian company offers a broad portfolio of over 500 commercial products across multiple therapeutic categories, including anaesthetics, anti-infectives, cardiovascular, central nervous system, and nutritional supplements. The company focuses on continuous innovation, developing complex generics supported by robust R&D, clinical trials, regulatory compliance, and intellectual property expertise. Ratnatris maintains stringent quality standards aligned with WHO cGMP and ISO 9001:2008, and holds certifications from various national health authorities. | |
Calypso Hospitality LLP | |
Sumer Enterprises LLP | |
Renosen Pharmaceuticals Pvt Ltd. | |
Espee Therapeutics LLP | |
Aelius Projects LLP |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale